Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02456233 · ClinicalTrials.gov registry record · NA
Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF
A NA study of Atrial Fibrillation, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 2
- Study locations
NCT02456233: Completed NA study of Atrial Fibrillation, sponsored by Stanford University.
NCT02456233 is a NA study of Atrial Fibrillation that has completed, run by Stanford University. The registered enrollment target is 84 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02456233, a NA study of Atrial Fibrillation, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 2
- Study locations
Study Summary
This prospective randomized study will assess the safety and efficacy of FIRM-guided ablation (FIRM+PVI) compared to pulmonary vein isolation (PVI) without FIRM, for the treatment of symptomatic atrial fibrillation.
Primary Outcome
Freedom from atrial fibrillation (AF) recurrence during the 12 months after the initial AF ablation procedure, after an initial 3 month blanking (healing and stabilization) period.
Conditions Studied
Interventions
- PROCEDURE Conventional AF Ablation with PVI
- PROCEDURE FIRM-guided ablation plus PVI
Study Locations (2)
California
- Veterans Affairs Medical Center - San Diego
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-04 |
| Est. Completion | 2025-02 |
| Phase | NA |
What the finished NCT02456233 record still lists
NCT02456233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Conventional AF Ablation with PVI is the first listed.
NCT02456233 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02456233 about?
NCT02456233 is a clinical study titled "Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF". This prospective randomized study will assess the safety and efficacy of FIRM-guided ablation (FIRM+PVI) compared to pulmonary vein isolation (PVI) without FIRM, for the treatment of symptomatic atrial fibrillation.
What is the current status of trial NCT02456233?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2016-04. Estimated completion is 2025-02.
What conditions does trial NCT02456233 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT02456233?
The interventions under investigation include: Conventional AF Ablation with PVI (PROCEDURE), FIRM-guided ablation plus PVI (PROCEDURE).
Who is sponsoring clinical trial NCT02456233?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02456233 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02456233's enrollment target sits among peer trials
84 150th of 202 higher than 52 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia